Page last updated: 2024-09-03

gr 65630 and ramosetron

gr 65630 has been researched along with ramosetron in 1 studies

Compound Research Comparison

Studies (gr 65630)	Trials (gr 65630)	Recent Studies (post-2010) (gr 65630)	Studies (ramosetron)	Trials (ramosetron)	Recent Studies (post-2010) (ramosetron)
57	0	4	194	94	83

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hidaka, K; Honda, K; Ito, H; Kamato, T; Miyata, K; Nishida, A	1

Other Studies

1 other study(ies) available for gr 65630 and ramosetron

Article	Year
Characterization of YM060, a potent and selective 5-hydroxytryptamine3 receptor antagonist, in rabbit nodose ganglion and N1E-115 neuroblastoma cells. The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:3 Topics: Animals; Benzimidazoles; Imidazoles; Indoles; Male; Neuroblastoma; Neurons; Nodose Ganglion; Rabbits; Serotonin; Serotonin Antagonists; Tumor Cells, Cultured	1992

Article

Year

Characterization of YM060, a potent and selective 5-hydroxytryptamine3 receptor antagonist, in rabbit nodose ganglion and N1E-115 neuroblastoma cells.

The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:3

Topics: Animals; Benzimidazoles; Imidazoles; Indoles; Male; Neuroblastoma; Neurons; Nodose Ganglion; Rabbits; Serotonin; Serotonin Antagonists; Tumor Cells, Cultured

1992